SCHEMBL10179645

SCHEMBL10179645

COCc1cc(Cl)cc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.58
ALDH1A1 P00352 3/20 0.58
MAPK1 P28482 1/20 0.37
GRIN2D O15399 4/20 0.36
GRIN3B O60391 4/20 0.36
GRIN1 Q05586 4/20 0.36
GRIN2A Q12879 4/20 0.36
GRIN2B Q13224 4/20 0.36
GRIN2C Q14957 4/20 0.36
GRIN3A Q8TCU5 4/20 0.36
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
BLM P54132 1/20 0.35
S1PR4 O95977 4/20 0.35
HPD P32754 2/20 0.33
VCAM1 P19320 1/20 0.33
DCTPP1 Q9H773 1/20 0.33
LMNA P02545 2/20 0.33
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29005669 0.91 ALDH1A1 (0.48) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL10180606 0.84 ALDH1A1 (0.55) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL10181559 0.83 TSHR (0.53) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL10181382 0.81 TSHR (0.51) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL10181446 0.79 ALDH1A1 (0.49) TSHRALDH1A1GRIN2DGRIN3BGRIN1
SCHEMBL5131993 0.77 ALDH1A1 (0.64) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL10179648 0.77 ALDH1A1 (0.64) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL7107938 0.77 ALDH1A1 (0.40) TSHRALDH1A1MAPK1GRIN2DGRIN3B
SCHEMBL18829973 0.75 ALDH1A1 (0.41) TSHRALDH1A1MAPK1MAPTTDP1
SCHEMBL954217 0.75 ALDH1A1 (1.00) TSHRALDH1A1MAPK1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2474536-B1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL IND CO (JP) 2014-06-25 EP disclosed
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF IHARA CHEMICAL INDUSTRY CO., LTD (JP) 2012-07-12 US disclosed
EP-2474536-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF Ihara Chemical Industry Co., Ltd. (JP) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178931-A1 PROCESS FOR PREPARATION OF PYRIMIDINYLACETONITRILE DERIVATIVES AND INTERMEDIATES FOR SYNTHESIS THEREOF DPYD, UMPS, PNP TSHR 3409/4885ALDH1A1 238/4885MAPK1 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.